Facilitated By

San Antonio Medical Foundation

News

  • Capital Impact Advisors Has Upped Its Matador Res Co (MTDR) Stake; Meridian Bioscience (VIVO ...

    Capital Impact Advisors Llc increased Matador Res Co (MTDR) stake by 28% reported in 2018Q2 SEC filing. Capital Impact Advisors Llc acquired ...

  • Arvinas Presents Preclinical Data on Protein Degrader, ARV-471, at the 2018 San Antonio Breast ...

    07, 2018 (GLOBE NEWSWIRE) -- Arvinas Inc. (Nasdaq:ARVN), a biotechnology company creating a new class of drugs based on targeted protein ...

  • Is It Time to Start Worrying About the Stock Market?

    Medical device maker Boston Scientific Corp. up 43 percent this year, was down 3.51 precent today and biotech firm Alexion Pharmaceuticals fell 4.49 ...

  • Initial public offerings scheduled to debut next week

    Business: Principal biotech developing immunotherapies for solid tumors. Tencent Music Entertainment - Shenzhen, China, 82 million shares, priced ...

  • Samsung Bioepis Announces Results of Additional One-Year Follow-Up Study Comparing Event ...

    The study results are being presented at the 2018 San Antonio Breast ... (SABCS) which is being held December 4-8, 2018 in San Antonio, Texas. ... KEYWORD: HEALTH BIOTECHNOLOGY ONCOLOGY PHARMACEUTICAL.